在心脏导管过程中增加了propranolol和diazepam的血自由药物度
Circulation
|November 1, 1980
概括
氨酸在心脏导管过程中显著增加了自由甲醇和甲水平. 这可能会导致患者的药物效应增强,如镇静或呼吸抑制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 临床化学 临床化学
背景情况:
- 心脏导管患者经常使用普罗普兰诺洛和西巴姆.
- 药物的有效性取决于未结合的血水平.
- 肝素对蛋白质结合的影响需要研究.
研究的目的:
- 为了评估肝素对自由普罗普拉诺洛尔和西巴姆水平的影响.
- 了解这些变化的潜在临床影响.
主要方法:
- 研究了6名接受心脏导管治疗的患者.
- 在肝素化之前和之后测量了普拉诺洛尔和泽帕姆的自由分数和水平.
- 监测的自由脂肪酸水平.
主要成果:
- 氨酸增加了大泽帕姆的自由分数超过四倍 (1.8%至7.9%) 和自由水平 (2.0至8.4 ng/ml).
- 氨酸增加了普罗普拉诺洛尔的自由分数 (7.4%至12.5%).
- 增加的自由脂肪酸与增加的自由药物度相关.
结论:
- 在心脏导管治疗期间的肝素化显著改变了propranolol和diazepam的蛋白质结合.
- 增加的自由药物水平可能会增强药理学效应,包括镇静和呼吸抑制.
相关概念视频
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Cardiac Catheterization II: Right Heart Catheterization
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...


